Home Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells
Article
Licensed
Unlicensed Requires Authentication

Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells

  • Theodoros Eleftheriadis EMAIL logo , Georgios Pissas , Spyridon Golfinopoulos , Vassilios Liakopoulos and Ioannis Stefanidis
Published/Copyright: August 2, 2022

Abstract

Objectives

Ischemia–reperfusion (I–R) injury is the most common cause of acute kidney injury (AKI). Experimental studies have shown that indoleamine 2,3-dioxygenase 1 (IDO) and the purinergic receptor P2X7 contribute to kidney I–R injury. We evaluated whether there is an interplay between IDO and P2X7 in the pathogenesis of I–R injury.

Methods

Primary renal proximal tubular epithelial cells (RPTECs) were subjected to anoxia or reoxygenation with or without specific inhibitors. Cell imaging, colorimetric assays, and Western blotting were used.

Results

Cell imaging revealed that inhibition of IDO, or all the purinergic receptors with an ATPase, or specific inhibition of P2X7 rescued the cells from anoxia or reoxygenation-induced cell death. This was confirmed with LDH release assay, which also detected the ferroptotic nature of cell death due to reoxygenation. On the contrary, activated cleaved caspase 3 increased during anoxia, showing that apoptosis prevails. All the aforementioned treatments prevented caspase increase. Both anoxia and reoxygenation increased extracellular ATP, IDO, and P2X7 expression. IDO remained unaffected by the above-mentioned treatments. On the contrary, treatment with apyrase or inhibition of P2X7decreased extracellular ATP and P2X7 expression, which are also decreased by inhibition of IDO. The first indicates a positive feedback loop regarding P2X7 activation, expression and function, while the latter implies that IDO controls P2X7 expression.

Conclusions

In RPRECs subjected to anoxia or reoxygenation, IDO is upregulated, increasing P2X7 and contributing to anoxia or reoxygenation-induced cell death. Clarifying the molecular mechanisms implicated in kidney I–R injury is of particular interest since it may lead to new therapeutic strategies against AKI.


Corresponding author: Theodoros Eleftheriadis, MD, PhD, Department of Nephrology, Faculty of Medicine, University of Thessaly, Biopolis, Mezourlo Hill, 41110 Larissa, Greece, Phone: 00302413501665, Fax: 00302413501667, E-mail:
Theodoros Eleftheriadis and Georgios Pissas contributed equally.
  1. Research funding: None, the project was supported by the resources of our department.

  2. Author contribution: T.E. designed the study, T.E. and G.P. performed the experiments, T.E., G.P., S.G., V.L., and I.S. analyzed the results, T.E. wrote the manuscript with help from G.P. I.S. supported all stages.

  3. Competing interests: The authors declare that they have no competing interests.

  4. Availability of data and materials: The analyzed datasets generated during the study are available from the corresponding author on reasonable request.

  5. Research involving Human Participants and/or Animals: Not applicable.

References

1. Neri, M, Riezzo, I, Pascale, N, Pomara, C, Turillazzi, E. Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediat Inflamm 2017;2017:7018393. https://doi.org/10.1155/2017/7018393.Search in Google Scholar PubMed PubMed Central

2. Bakthavachalam, P, Shanmugam, PST. Mitochondrial dysfunction – silent killer in cerebral ischemia. J Neurol Sci 2017;375:417–23. https://doi.org/10.1016/j.jns.2017.02.043.Search in Google Scholar PubMed

3. Tsukamoto, T, Chanthaphavong, RS, Pape, HC. Current theories on the pathophysiology of multiple organ failure after trauma. Injury 2010;41:21–6. https://doi.org/10.1016/j.injury.2009.07.010.Search in Google Scholar PubMed

4. Ronco, C, Bellomo, R, Kellum, JA. Acute kidney injury. Lancet 2019;394:1949–64. https://doi.org/10.1016/s0140-6736(19)32563-2.Search in Google Scholar PubMed

5. Hsu, CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol 2012;23:967–9. https://doi.org/10.1681/ASN.2012030222.Search in Google Scholar PubMed

6. Bonventre, JV, Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011;121:4210–21. https://doi.org/10.1172/JCI45161.Search in Google Scholar PubMed PubMed Central

7. Mohib, K, Wang, S, Guan, Q, Mellor, AL, Sun, H, Du, C, et al.. Indoleamine 2, 3-dioxygenase expression promotes renal ischemia-reperfusion injury. Am J Physiol Ren Physiol 2008;295:F226–34. https://doi.org/10.1152/ajprenal.00567.2007.Search in Google Scholar PubMed PubMed Central

8. Eleftheriadis, T, Pissas, G, Antoniadi, G, Liakopoulos, V, Stefanidis, I. Cell death patterns due to warm ischemia or reperfusion in renal tubular epithelial cells originating from human, mouse, or the native hibernator hamster. Biology 2018;7. https://doi.org/10.3390/biology7040048.Search in Google Scholar PubMed PubMed Central

9. Eleftheriadis, T, Pissas, G, Liakopoulos, V, Stefanidis, I. Factors that may protect the native hibernator Syrian hamster renal tubular epithelial cells from ferroptosis due to warm anoxia-reoxygenation. Biology 2019;8. https://doi.org/10.3390/biology8020022.Search in Google Scholar PubMed PubMed Central

10. Linkermann, A, Skouta, R, Himmerkus, N, Mulay, SR, Dewitz, C, De Zen, F, et al.. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci 2014;111:16836–41. https://doi.org/10.1073/pnas.1415518111.Search in Google Scholar PubMed PubMed Central

11. Eleftheriadis, T, Pissas, G, Golfinopoulos, S, Liakopoulos, V, Stefanidis, I. Role of indoleamine 2, 3-dioxygenase in ischemia-reperfusion injury of renal tubular epithelial cells. Mol Med Rep 2021;23. https://doi.org/10.3892/mmr.2021.12111.Search in Google Scholar PubMed PubMed Central

12. Eleftheriadis, T, Pissas, G, Filippidis, G, Liakopoulos, V, Stefanidis, I. The role of indoleamine 2, 3-dioxygenase in renal tubular epithelial cells senescence under anoxia or reoxygenation. Biomolecules 2021;11:1522. https://doi.org/10.3390/biom11101522.Search in Google Scholar PubMed PubMed Central

13. Roberts, V, Campbell, DJ, Lu, B, Chia, J, Cowan, PJ, Dwyer, KM. The differential effect of apyrase treatment and hCD39 overexpression on chronic renal fibrosis after ischemia-reperfusion injury. Transplantation 2017;101:e194–204. https://doi.org/10.1097/tp.0000000000001679.Search in Google Scholar

14. Yan, Y, Bai, J, Zhou, X, Tang, J, Jiang, C, Tolbert, E, et al.. P2X7 receptor inhibition protects against ischemic acute kidney injury in mice. Am J Physiol Cell Physiol 2015;308:C463–72. https://doi.org/10.1152/ajpcell.00245.2014.Search in Google Scholar PubMed PubMed Central

15. Qian, Y, Qian, C, Xie, K, Fan, Q, Yan, Y, Lu, R, et al.. P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury. Cell Death Dis 2021;12. https://doi.org/10.1038/s41419-020-03384-y.Search in Google Scholar PubMed PubMed Central

16. Burnstock, G, Verkhratsky, A. Mechanisms of ATP release and inactivation. In: Purinergic Signalling and the Nervous System. Berlin, Heidelberg: Springer; 2012:79–118 pp. https://doi.org/10.1007/978-3-642-28863-0_4.Search in Google Scholar

17. Dosch, M, Gerber, J, Jebbawi, F, Beldi, G. Mechanisms of ATP release by inflammatory cells. Int J Mol Sci 2018;19:1222. https://doi.org/10.3390/ijms19041222.Search in Google Scholar PubMed PubMed Central

18. Martínez-Cuesta, MÁ, Blanch-Ruiz, MA, Ortega-Luna, R, Sánchez-López, A, Álvarez, Á. Structural and functional basis for understanding the biological significance of P2X7 receptor. Int J Mol Sci 2020;21:8454. https://doi.org/10.3390/ijms21228454.Search in Google Scholar PubMed PubMed Central

19. Lobner, D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods 2000;96:147–52. https://doi.org/10.1016/s0165-0270(99)00193-4.Search in Google Scholar PubMed

20. D’Arcy, MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 2019;43:582–92. https://doi.org/10.1002/cbin.11137.Search in Google Scholar PubMed

21. Fdr, M, Gonzalez, NS, Communi, D, Goldman, M, Boeynaems, J-M, Communi, D. Thrombospondin-1 and indoleamine 2, 3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 2005;106:3860–6. https://doi.org/10.1182/blood-2005-05-1843.Search in Google Scholar PubMed

22. Lecciso, M, Ocadlikova, D, Sangaletti, S, Trabanelli, S, De Marchi, E, Orioli, E, et al.. ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells. Front Immunol 2017;8. https://doi.org/10.3389/fimmu.2017.01918.Search in Google Scholar PubMed PubMed Central

23. Tung, LT, Wang, H, Belle, JI, Petrov, JC, Langlais, D, Nijnik, A. p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress. Cell Death Dis 2021;12. https://doi.org/10.1038/s41419-021-04202-9.Search in Google Scholar PubMed PubMed Central

24. Eleftheriadis, T, Pissas, G, Antoniadi, G, Spanoulis, A, Liakopoulos, V, Stefanidis, I. Indoleamine 2, 3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2, 3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation. Int Immunol 2014;26:673–84. https://doi.org/10.1093/intimm/dxu077.Search in Google Scholar PubMed

25. Tang, K, Wu, YH, Song, Y, Yu, B. Indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. J Hematol Oncol 2021;14. https://doi.org/10.1186/s13045-021-01080-8.Search in Google Scholar PubMed PubMed Central


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/JBCPP-2022-0128).


Received: 2022-05-09
Accepted: 2022-07-03
Published Online: 2022-08-02

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Breaking the mold: revolutionary new obesity drugs set to transform treatment landscape?
  4. Reviews
  5. The relationship between the history of PDE5-inhibitors assumption and melanoma: a systematic review
  6. Stem cell therapy in sports medicine: current applications, challenges and future perspectives
  7. Original Articles
  8. Modulatory action of Moringa oleifera Lam. on L-arginine induced acute pancreatitis
  9. Isotonic saline causes greater volume overload than electrolyte-free irrigating fluids
  10. Anti-atherosclerotic activity of aqueous extract of Ipomoea batatas (L.) leaves in high-fat diet-induced atherosclerosis model rats
  11. Efficacy of Habb-e-Asab in diabetic peripheral neuropathy: a randomized placebo control study
  12. Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells
  13. Effect of habitual breakfast skipping on information processing capacity, cortical response, and cognitive flexibility among medical collegiate – a cross-sectional study
  14. Association of neck circumference and waist-hip ratio with total leukocyte count in healthy Indian adolescents
  15. 3-Day food record: efficacy in patients with type 2 diabetes mellitus
  16. Development and user acceptability testing of healthy heart mobile application – a tool for cardiovascular risk modification among patients with type 2 diabetes mellitus
  17. Effectiveness of electrical vestibular nerve stimulation on the range of motion in patients with Parkinson’s disease
  18. Intra-operative drug level monitoring of pre-operative antibiotic for surgical prophylaxis in the patients of elective spinal surgery
  19. Case Report
  20. The black swan: a case of central nervous system graft-versus-host disease
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2022-0128/html
Scroll to top button